Biodexa Pharmaceuticals Plc - BDRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Armistice Capital, LLC | 9.99% | 283,502 | View |
| Feb 17, 2026 | SCHEDULE 13G | Steven Boyd | 9.99% | 283,502 | View |
| Jan 20, 2026 | SCHEDULE 13G | SABBY MANAGEMENT, LLC | 9.9% | 217,600 | View |
| Jan 20, 2026 | SCHEDULE 13G | Hal Mintz | 9.9% | 217,600 | View |
| Jan 20, 2026 | SCHEDULE 13G | Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 217,600 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cavalry Fund I LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | C/M CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cavalry Investment Fund, LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cavalry Fund I Management LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Mercer Street Global Opportunity Fund, LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Mercer Street Capital Partners, LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Thomas Walsh | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Jonathan Juchno | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.